Absci Announces Collaboration with AstraZeneca to Advance AI-Driven Oncology Candidate

Collaboration Combines Absci’s AI Antibody Drug Creation Platform with AstraZeneca’s Expertise in Oncology Research and DevelopmentVANCOUVER, Wash., Dec. 04, 2023 -- Absci Corporation , a...

Related Keywords

New York ,United States ,Switzerland ,Vancouver ,British Columbia ,Canada ,Sean Mcclain ,Alex Khan ,Astrazeneca Expertise In Oncology Research ,Ai Research Lab ,Astrazeneca ,Absci Corporation Nasdaq ,Innovation Center ,Exchange Commission ,Youtube ,Securities Exchange ,Linkedin ,Collaboration Combines Absci ,Drug Creation Platform ,Oncology Research ,Integrated Drug Creation ,Absci Founder ,Drug Creation ,Senior Vice President ,Biologics Engineering ,Oncology Targeted Delivery ,New York City ,Securities Act ,Securities Exchange Act ,Markets ,